Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

The Salivary Hormone Profile in the Clinical Evaluation of Women

Author(s):  Stephenson Kenna

Issue:  Nov/Dec 2004 - Endotoxin
View All Articles in Issue

Page(s):  427-435

The Salivary Hormone Profile in the Clinical Evaluation of Women Page 1
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 2
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 3
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 4
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 5
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 6
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 7
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 8
The Salivary Hormone Profile in the Clinical Evaluation of Women Page 9

Download in electronic PDF format for $75

Abstract:  Estrogens, progesterone, testosterone, dehydroepiandosterone, and cortisol play vital roles in many aspects of a woman’s physiology and quality of life. A wide variety of symptoms and medical conditions are completely or partially due to elevations or deficiencies of sex hormones in women. Often a clinician suspects that a patient’s symptoms are related to hormone irregularities, but conventional diagnostic serum testing shows hormone levels in the normal ranges. Serum is only one reservoir or sex hormones in the body, and thus serum level does not accurately reflect sex hormone bioavailability. Salivary hormone analysis, on the other hand, offers accurate and comprehensive assessment of hormone bioavailability at the tissue level, from all reservoirs. Reference values for salivary hormone testing have been established for women. Saliva testing is more convenient for the patient and costs less than serum testing, yet it has not been accepted into mainstream medicine. Disadvantages of salivary hormone testing include poor correlation with serum results in women receiving hormone replacement therapy and the potential for contamination of samples. These disadvantages can be overcome with careful sample collection technique and adjusting for the patient’s hormone replacement therapy status. Salivary hormone assay can be adapted by primary care providers to assist in the diagnosis and treatment of conditions related to sex hormone imbalances in women.

Related Keywords: saliva testing, hormone levels, hormone imbalance, menopause, perimenopause, hormone deficiency, signs and symptoms, women

Related Categories: HRT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
The Salivary Hormone Profile in the Clinical Evaluation of Women
Stephenson Kenna
Nov/Dec 2004
Pg. 427-435

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John
, Dollbaum Charles M
Sep/Oct 2009
Pg. 392-399

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
Jan/Feb 2004
Pg. 16-21

Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Gillson George R
, Zava David T
Sep/Oct 2003
Pg. 330-338

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J
, Ahlgrimm Maria
Mar/Apr 2008
Pg. 122-127

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Cutter Christopher B
Mar/Apr 2004
Pg. 96-99

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation
Kells John
, Dollbaum Charles M
Jul/Aug 2009
Pg. 280-288

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris
, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010
Pg. 165-170

The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Holt-Waldo NaRisa Y
, Stephenson Kenna
Jul/Aug 2007
Pg. 292-296

The Value of Hormone Assessment
Collins Joseph J
Sep/Oct 2001
Pg. 342-344

Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom
, Taylor Sarah, Zander Clark
Mar/Apr 2021
Pg. 156-162

Return to Top